Joaquin Duato has been leading Johnson & Johnson as CEO since January 2022, after a career at the company spanning over 30 years. He began with Janssen-Farmaceutica in Spain and progressed through various roles in pharmaceuticals and consumer health. This...
Joaquin Duato has been leading Johnson & Johnson as CEO since January 2022, after a career at the company spanning over 30 years. He began with Janssen-Farmaceutica in Spain and progressed through various roles in pharmaceuticals and consumer health. This deep experience gives him a solid understanding of the business. Duato holds an MBA from ESADE in Spain and a Master's in International Management from Thunderbird in Arizona, showcasing his educational background. He is a dual citizen of Spain and the U.S., which provides him with a unique global perspective. In 2023, Duato earned a total compensation of $2.1 million, mainly tied to meeting key business goals. His financial stake in Johnson & Johnson is substantial, with stock holdings valued over $48 million, reflecting his confidence in the company's success. Under his leadership, Duato focuses on sustainable growth and addressing challenges while balancing financial health with strategic opportunities. Recently, he was appointed Chairman of the Board, further solidifying his role at the helm of this healthcare giant.